Form 10-Q Bionano Genomics, Inc. For: Sep 30

Go back to Form 10-Q Bionano Genomics, Inc. For: Sep 30

BTIG Reiterates Neutral Rating on Bionano Genomics (BNGO)

November 18, 2024 7:25 AM EST

BTIG analyst Mark Massaro reiterated a Neutral rating on Bionano Genomics (NASDAQ: BNGO).

The analyst comments "Bionano delivered a Q3 miss, and again lowered its 2024 guide in part to reflect its newer focus on driving consumables growth and reducing its emphasis on driving... More